Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC
Clinical trial NCT05691829 · TERMINATED
Trial details
- NCT number
- NCT05691829
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-24
- Primary completion
- 2024-06-20
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.